Impact BioMedical Inc. (IBO) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 377K | 411K | 917K | 1.48M | 2.18M | 2.45M | 3.17M | 307K | 335K | 332K | 680 | 461 | 595.08K | 122K | 859.63K | 1.02M | 2.3M | 287K | 4.91M | 5.11M |
| Cash & Short-Term Investments | 20K | 3K | 12K | 624K | 1.32M | 2M | 2.67M | 2K | 2K | 1K | 273 | 4 | 353.05K | 2K | 703.67K | 726.05K | 1.95M | 46K | 4.19M | 53.06K |
| Cash Only | 20K | 3K | 12K | 624K | 1.32M | 2M | 2.67M | 2K | 2K | 1K | 273 | 4 | 353.05K | 2K | 703.67K | 726.05K | 1.95M | 46K | 4.19M | 53.06K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 199K | 203K | 214K | 200K | 204K | 184K | 142K | 263K | 331K | 331K | 130 | 0 | 135.21K | 16K | 116.57K | 231K | 209.33K | 197K | 450.69K | 11.19K |
| Days Sales Outstanding | 2.58K | 2.74K | 1.06K | 2.63K | - | - | - | - | - | - | - | - | 115.22 | 141.52 | - | 642.66 | 206.99 | 166 | - | - |
| Inventory | 63K | 63K | 485K | 486K | 489K | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 19.89 | 59.73 | 44.67K | 4.03K | 155.51 | - | - | - | - | - | - | 0.01 | - | - | - | - | - | - | - | - |
| Other Current Assets | 95K | 0 | 206K | 171K | 172K | 0 | 365K | 42K | 2K | 0 | 277 | 452 | 0 | 43K | 0 | 0 | 0 | 1K | 0 | 5.04M |
| Total Non-Current Assets | 16.71M | 16.99M | 17.29M | 17.58M | 17.87M | 17.84M | 43.52M | 43.81M | 44.02M | 44.3M | 60.55K | 60.46K | 5.28M | 46.38M | 5.38M | 5.3M | 8.07M | 56.14M | 8.14M | 892 |
| Property, Plant & Equipment | 0 | 0 | 13K | 14K | 16K | 17K | 282K | 284K | 285K | 287K | 393 | 384 | 3.73M | 276K | 5.38M | 5.3M | 6.61M | 0 | 6.68M | 892 |
| Fixed Asset Turnover | - | - | 1.33x | 0.47x | - | - | - | - | - | - | - | - | 0.11x | 0.15x | - | 0.02x | 0.06x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 4.45M | 25.09M | 25.09M | 25.09M | 25.09M | 34.08K | 33.24K | 0 | 25.09M | 0 | 0 | 1.46M | 25.09M | 1.46M | 0 |
| Intangible Assets | 16.71M | 16.99M | 17.28M | 17.57M | 17.85M | 13.36M | 18.09M | 18.36M | 18.64M | 18.92M | 26.08K | 25.8K | 0 | 20.03M | 0 | 0 | 0 | 21.15M | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 17K | 59K | 67K | 0 | 0 | 0 | 1.03K | 0 | 782K | 0 | 0 | 0 | 4.82M | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.55M | 190K | 0 | 0 | 0 | 5.08M | 0 | 0 |
| Total Assets | 17.09M | 17.41M | 18.21M | 19.06M | 20.05M | 20.29M | 46.7M | 44.12M | 44.36M | 44.63M | 61.23K | 60.92K | 5.87M | 46.5M | 6.24M | 6.32M | 10.37M | 56.42M | 13.05M | 5.11M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | - | - | - | - | - | - | - | - | 0.07x | 0.00x | - | 0.02x | 0.04x | 0.01x | - | - |
| Asset Growth % | -14.79% | -14.22% | -61.01% | - | - | - | - | 72311.53% | 655.02% | -4.01% | -99.02% | -99.04% | -43.33% | -17.59% | -52.2% | 23.65% | 371.49% | 77466.53% | 10812.62% | 3076.96% |
| Total Current Liabilities | 1.69M | 1.16M | 23.79M | 23.17M | 9.97M | 9.79M | 1.14M | 14.5M | 13.86M | 13.14M | 16.66K | 15.97K | 1.15M | 10.59M | 2.28M | 2.19M | 957.16K | 12.64M | 1.38M | 5.08M |
| Accounts Payable | 374K | 347K | 576K | 554K | 615K | 713K | 1M | 986K | 1.02M | 832K | 647 | 399 | 361.2K | 539K | 172.42K | 171.79K | 278.78K | 115K | 477.05K | 0 |
| Days Payables Outstanding | 113.84 | 100.61 | 51.98K | 4.84K | 211.17 | - | 1.3K | - | - | - | 0.84 | 0.52 | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 22.88M | 22.35M | 9.14M | 8.88M | 35K | 13.45M | 12.79M | 12.07M | 16K | 15.57K | 102.9K | 9.99M | 1.54M | 1.56M | 188.42K | 12.52M | 436.81K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 304.8K | 0 | 165.9K | 165.9K | 179.11K | 0 | 20.18K | 0 |
| Other Current Liabilities | 1.31M | 815K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.08M |
| Current Ratio | 0.22x | 0.35x | 0.04x | 0.06x | 0.22x | 0.25x | 2.79x | 0.02x | 0.02x | 0.03x | 0.04x | 0.03x | 0.52x | 0.01x | 0.38x | 0.46x | 2.40x | 0.02x | 3.55x | 1.01x |
| Quick Ratio | 0.19x | 0.30x | 0.02x | 0.04x | 0.17x | 0.25x | 2.79x | 0.02x | 0.02x | 0.03x | 0.04x | 0.03x | 0.52x | 0.01x | 0.38x | 0.46x | 2.40x | 0.02x | 3.55x | 1.01x |
| Cash Conversion Cycle | 2.49K | 2.7K | -6.26K | 1.82K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 688K | 688K | 3.27M | 3.27M | 3.27M | 3.27M | 11.21M | 3.23M | 3.23M | 3.23M | 4.39K | 4.29K | 2.53M | 3.23M | 748.22K | 180K | 1.67M | 3.86M | 1.72M | 60K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 7.97M | 0 | 0 | 0 | 0 | 0 | 2.5M | 0 | 748.22K | 180K | 1.67M | 0 | 1.72M | 60K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 688K | 688K | 3.27M | 3.27M | 3.27M | 3.27M | 3.23M | 3.23M | 3.23M | 3.23M | 0 | 0 | 0 | 3.23M | 0 | 0 | 0 | 3.86M | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.39K | 4.29K | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 |
| Total Liabilities | 2.38M | 1.85M | 27.06M | 26.44M | 13.24M | 13.05M | 12.34M | 17.73M | 17.09M | 16.37M | 21.05K | 20.25K | 3.67M | 13.83M | 3.03M | 2.37M | 2.63M | 16.5M | 3.11M | 5.14M |
| Total Debt | 0 | 0 | 22.88M | 22.35M | 9.14M | 8.88M | 8.01M | 13.45M | 12.79M | 12.07M | 16K | 15.57K | 2.65M | 9.99M | 2.3M | 1.74M | 1.86M | 12.52M | 2.16M | 60K |
| Net Debt | -20K | -3K | 22.87M | 21.73M | 7.82M | 6.88M | 5.34M | 13.45M | 12.79M | 12.07M | 15.73K | 15.57K | 2.3M | 9.99M | 1.6M | 1.01M | -94.46K | 12.48M | -2.03M | 6.94K |
| Debt / Equity | - | - | - | - | 1.34x | 1.23x | 0.23x | 0.51x | 0.47x | 0.43x | 0.40x | 0.38x | 1.21x | 0.31x | 0.72x | 0.44x | 0.24x | 0.31x | 0.22x | - |
| Debt / EBITDA | - | - | 78.09x | - | - | - | - | - | - | - | - | - | 18.89x | - | - | 49.10x | 7.70x | 33.83x | - | - |
| Net Debt / EBITDA | - | - | 78.05x | - | - | - | - | - | - | - | - | - | 16.37x | - | - | 28.59x | -0.39x | 33.71x | - | - |
| Interest Coverage | - | - | -4.63x | -54.20x | -3.72x | -99.37x | 14.90x | -2.40x | -3.35x | -9.11x | -8044.78x | -6765.10x | 1.24x | -3.98x | -3.51x | -3.64x | 16.66x | 13.94x | -41.22x | - |
| Total Equity | 14.71M | 15.55M | -8.85M | -7.38M | 6.81M | 7.24M | 34.35M | 26.38M | 27.26M | 28.26M | 40.18K | 40.67K | 2.2M | 32.67M | 3.21M | 3.94M | 7.74M | 39.92M | 9.94M | -27.62K |
| Equity Growth % | 116.02% | 114.94% | -125.77% | - | - | - | - | 64770.05% | 1139.37% | -13.49% | -98.75% | -98.97% | -71.57% | -18.17% | -67.73% | 14375.19% | 173737.58% | 755806.98% | 20441.86% | -123.1% |
| Book Value per Share | 0.14 | 0.49 | -0.73 | -0.61 | 0.56 | 0.63 | 0.48 | 2.29 | 2.37 | 0.96 | 0.57 | 0.58 | 0.01 | 0.17 | 0.02 | 0.02 | 0.04 | 0.21 | 0.06 | -0.00 |
| Total Shareholders' Equity | 11.46M | 12.61M | -11.81M | -10.34M | 3.84M | 4.26M | 31.35M | 23.37M | 24.26M | 25.22M | 36.01K | 36.59K | 2.2M | 29.56M | 3.21M | 3.94M | 7.74M | 36.61M | 9.94M | -27.62K |
| Common Stock | 108K | 105K | 12K | 12K | 12K | 11K | 11K | 10K | 10K | 10K | 95 | 166 | 22.83M | 70K | 22.81M | 22.8M | 20.17M | 125K | 20.15M | 791K |
| Retained Earnings | -51.79M | -49.51M | -54.75M | -53.28M | -38.94M | -37.67M | -10.56M | -14.81M | -13.92M | -12.96M | -15.85K | -13.99K | -24.86M | -8.63M | -23.58M | -22.74M | -16.19M | -1.57M | -13.98M | -938.52K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | - | - |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.23M | 0 | 3.98M | 5.48K | 3.76M | 0 | 3.77M | 0 |
| Minority Interest | 3.25M | 2.95M | 2.96M | 2.96M | 2.97M | 2.98M | 3M | 3.01M | 3M | 3.04M | 4.16K | 4.08K | 0 | 3.11M | 0 | 0 | 0 | 3.31M | 0 | 0 |